Hochschulschrift
MDM2 inhibition enhances the graft-versus-leukemia effect via TRAIL-R1/2 and MHC-II upregulation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
XIV, 165 Seiten
- Language
-
Englisch
- Notes
-
Illustrationen, Diagramme
Albert-Ludwigs-Universität Freiburg im Breisgau, Dissertation, 2023
- Keyword
-
Akute myeloische Leukämie
Stammzelltransplantation
Tumorzelle
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 1:49 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Time of origin
- [2023]
Other Objects (12)
TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes
TRAIL-receptor preferences in pancreatic cancer cells revisited: Both TRAIL-R1 and TRAIL-R2 have a licence to kill
Cytoplasmic TRAIL-R1 is a positive prognostic marker in PDAC
Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells
R1, 4 R1, 5 R1, 6
R1, 7 R1, 8 R1, 9
R1, 1 R1, 2 R1, 3
R1, 10 R1, 11 R1, 12
Simvastatin inhibits interferon-γ-induced MHC class II up-regulation in cultured astrocytes
2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2
The MDM2 gene family
MDM2 inhibition enhances immune checkpoint inhibitor efficacy by increasing IL-15 and MHC class II production by melanoma cells
TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes
TRAIL-receptor preferences in pancreatic cancer cells revisited: Both TRAIL-R1 and TRAIL-R2 have a licence to kill
Cytoplasmic TRAIL-R1 is a positive prognostic marker in PDAC
Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells
R1, 4 R1, 5 R1, 6
R1, 7 R1, 8 R1, 9
R1, 1 R1, 2 R1, 3
R1, 10 R1, 11 R1, 12
Simvastatin inhibits interferon-γ-induced MHC class II up-regulation in cultured astrocytes
2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2
The MDM2 gene family
MDM2 inhibition enhances immune checkpoint inhibitor efficacy by increasing IL-15 and MHC class II production by melanoma cells
TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes
TRAIL-receptor preferences in pancreatic cancer cells revisited: Both TRAIL-R1 and TRAIL-R2 have a licence to kill
Cytoplasmic TRAIL-R1 is a positive prognostic marker in PDAC
Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells
R1, 4 R1, 5 R1, 6
R1, 7 R1, 8 R1, 9
R1, 1 R1, 2 R1, 3
R1, 10 R1, 11 R1, 12
Simvastatin inhibits interferon-γ-induced MHC class II up-regulation in cultured astrocytes
2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2
The MDM2 gene family